Kazanietz MG - Search Results

1

Protein kinase C and cancer: what we know and what we do not.

Garg R, Benedetti LG, Abera MB, Wang H, Abba M, Kazanietz MG. Garg R, et al. Among authors: kazanietz mg. Oncogene. 2014 Nov 6;33(45):5225-37. doi: 10.1038/onc.2013.524. Epub 2013 Dec 16. Oncogene. 2014. PMID: 24336328 Free PMC article. Review.

2

Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway.

Barry OP, Kazanietz MG, Praticò D, FitzGerald GA. Barry OP, et al. Among authors: kazanietz mg. J Biol Chem. 1999 Mar 12;274(11):7545-56. doi: 10.1074/jbc.274.11.7545. J Biol Chem. 1999. PMID: 10066822 Free article.

3

Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta.

Fujii T, García-Bermejo ML, Bernabó JL, Caamaño J, Ohba M, Kuroki T, Li L, Yuspa SH, Kazanietz MG. Fujii T, et al. Among authors: kazanietz mg. J Biol Chem. 2000 Mar 17;275(11):7574-82. doi: 10.1074/jbc.275.11.7574. J Biol Chem. 2000. PMID: 10713064 Free article.

4

Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters.

Kazanietz MG. Kazanietz MG. Mol Carcinog. 2000 May;28(1):5-11. doi: 10.1002/(sici)1098-2744(200005)28:1<5::aid-mc2>3.0.co;2-g. Mol Carcinog. 2000. PMID: 10820483 Review.

5

Pharmacology of the receptors for the phorbol ester tumor promoters: multiple receptors with different biochemical properties.

Kazanietz MG, Caloca MJ, Eroles P, Fujii T, García-Bermejo ML, Reilly M, Wang H. Kazanietz MG, et al. Biochem Pharmacol. 2000 Nov 15;60(10):1417-24. doi: 10.1016/s0006-2952(00)00470-6. Biochem Pharmacol. 2000. PMID: 11020443 Free article.

6

Phorbol esters and related analogs regulate the subcellular localization of beta 2-chimaerin, a non-protein kinase C phorbol ester receptor.

Caloca MJ, Wang H, Delemos A, Wang S, Kazanietz MG. Caloca MJ, et al. Among authors: kazanietz mg. J Biol Chem. 2001 May 25;276(21):18303-12. doi: 10.1074/jbc.M011368200. Epub 2001 Feb 14. J Biol Chem. 2001. PMID: 11278894 Free article.

7

Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha.

Garcia-Bermejo ML, Leskow FC, Fujii T, Wang Q, Blumberg PM, Ohba M, Kuroki T, Han KC, Lee J, Marquez VE, Kazanietz MG. Garcia-Bermejo ML, et al. Among authors: kazanietz mg. J Biol Chem. 2002 Jan 4;277(1):645-55. doi: 10.1074/jbc.M107639200. Epub 2001 Oct 2. J Biol Chem. 2002. PMID: 11584014 Free article.

8

Chimaerins, novel non-protein kinase C phorbol ester receptors, associate with Tmp21-I (p23): evidence for a novel anchoring mechanism involving the chimaerin C1 domain.

Wang H, Kazanietz MG. Wang H, et al. Among authors: kazanietz mg. J Biol Chem. 2002 Feb 8;277(6):4541-50. doi: 10.1074/jbc.M107150200. Epub 2001 Oct 31. J Biol Chem. 2002. PMID: 11689559 Free article.

9

Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.

Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG. Tanaka Y, et al. Among authors: kazanietz mg. J Biol Chem. 2003 Sep 5;278(36):33753-62. doi: 10.1074/jbc.M303313200. Epub 2003 Jun 24. J Biol Chem. 2003. PMID: 12824193 Free article.

10

Pharmacological probes for protein kinase C: an introduction.

Kazanietz MG. Kazanietz MG. Methods Mol Biol. 2003;233:389-95. doi: 10.1385/1-59259-397-6:389. Methods Mol Biol. 2003. PMID: 12840524 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters